Follow
Varadha Balaji Venkadakrishnan
Varadha Balaji Venkadakrishnan
Dana-Farber Cancer Institute
Verified email at dfci.harvard.edu
Title
Cited by
Cited by
Year
A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer
S Liu, S Kumari, Q Hu, D Senapati, VB Venkadakrishnan, D Wang, ...
Elife 6, e28482, 2017
652017
Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer
MK Bakht, Y Yamada, SY Ku, VB Venkadakrishnan, JA Korsen, ...
Nature cancer 4 (5), 699-715, 2023
242023
Polymeric black tea polyphenols (PBPs) inhibit benzo (a) pyrene and 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone‐induced lung carcinogenesis potentially through down …
RR Hudlikar, VB Venkadakrishnan, R Kumar, RA Thorat, S Kannan, ...
Molecular carcinogenesis 56 (2), 625-640, 2017
242017
Novel insights in cell cycle dysregulation during prostate cancer progression
S Ben-Salem, VB Venkadakrishnan, HV Heemers
Endocrine-related cancer 28 (6), R141-R155, 2021
232021
Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells
MK Bakht, JJ Hayward, F Shahbazi-Raz, M Skubal, R Tamura, KF Stringer, ...
Proceedings of the National Academy of Sciences 119 (4), e2025710119, 2022
152022
AR-dependent phosphorylation and phospho-proteome targets in prostate cancer
VB Venkadakrishnan, S Ben-Salem, HV Heemers
Endocrine-related cancer 27 (6), R193-R210, 2020
122020
Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy
VB Venkadakrishnan, AD DePriest, S Kumari, D Senapati, S Ben-Salem, ...
Oncogene 38 (23), 4496-4511, 2019
112019
Diversity in androgen receptor action among treatment-naïve prostate cancers is reflected in treatment response predictions and molecular subtypes
S Ben-Salem, Q Hu, Y Liu, M Alshalalfa, X Zhao, I Wang, ...
European urology open science 22, 34-44, 2020
92020
Significance of RB loss in unlocking phenotypic plasticity in advanced cancers
VB Venkadakrishnan, Y Yamada, K Weng, O Idahor, H Beltran
Molecular Cancer Research 21 (6), 497-510, 2023
32023
CHD1 promotes sensitivity to aurora kinase inhibitors by suppressing interaction of AURKA with its coactivator TPX2
H Li, Y Wang, K Lin, VB Venkadakrishnan, M Bakht, W Shi, C Meng, ...
Cancer research 82 (17), 3088-3101, 2022
32022
Correction: A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer
S Liu, S Kumari, Q Hu, D Senapati, VB Venkadakrishnan, D Wang, ...
Elife 6, e33738, 2017
22017
Prostate cancer progression relies on the mitotic kinase citron kinase
C Rawat, S Ben-Salem, N Singh, G Chauhan, A Rabljenovic, V Vaghela, ...
Cancer Research 83 (24), 4142-4160, 2023
12023
Targeting DNA methylation and B7-H3 in RB1-deficient and neuroendocrine prostate cancer
Y Yamada, VB Venkadakrishnan, K Mizuno, M Bakht, SY Ku, MM Garcia, ...
Science Translational Medicine 15 (722), eadf6732, 2023
12023
Genomic alterations impact cell cycle-related genes during prostate cancer progression
S Ben-Salem, VB Venkadakrishnan, HV Heemers
Endocrine-related cancer 28 (6), L5-L10, 2021
12021
Erratum: Correction: A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer (eLife (2017) 6 PII: e33738)
S Liu, S Kumari, Q Hu, D Senapati, VB Venkadakrishnan, D Wang, ...
eLife 6, 2017
12017
Chemoprevention of lung cancer by polymeric black tea polyphenols (PBPs): Preclinical evaluation of potential molecular targets
R Hudlikar, V Venkadakrishnan, R Kaushal, R Thorat, S Kannan, A Ingle, ...
EUROPEAN JOURNAL OF CANCER 54, S69-S69, 2016
12016
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes
VB Venkadakrishnan, AG Presser, R Singh, MA Booker, NA Traphagen, ...
2024
SAT633 The RNA Helicase UPF1 Mediates AR-And SRF-dependent Transcription In Prostate Cancer
G Chauhan, VB Venkadakrishnan, U Dahiya, Y Ghanem, GJ Srinivasan, ...
Journal of the Endocrine Society 7 (Supplement_1), bvad114. 2203, 2023
2023
Abstract A015: Citron kinase is a novel driver of prostate cancer progression and controls alternative splicing associated with treatment-resistance
C Rawat, N Singh, G Chauhan, A Rabljenovic, S Ben-Salem, V Vaghela, ...
Cancer Research 83 (11_Supplement), A015-A015, 2023
2023
Abstract B017: Lineage-specific PRC2 targets and response to EZH2 inhibition in neuroendocrine prostate cancer
VB Venkadakrishnan, R Singh, Y Yamada, K Mizuno, AG Presser, SY Ku, ...
Cancer Research 83 (11_Supplement), B017-B017, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20